Hypothesizing that MSC-mediated plasmin activation may regulate IGF1 availability, we found that primary BCR-ABL1+ B-ALL cell numbers significantly increased when IGF1 was released from matrigel containing WT MSC after plasmin activation by plasminogen (Fig. 6A). The gene discussed is IGF1; the disease is precursor B-cell acute lymphoblastic leukemia.